Deep-pocketed investors have adopted a bullish approach towards Merck & Co MRK, and it's something market players shouldn't ...

Merck (MRK) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of ...

In 2018, Merck is determined to step up for patients. Patient centricity constitutes one of the priorities for the company’s two ... and facilitate information sharing with our external partners.

Earnings Per Share (TTM) A company's net income for the trailing ... refer to time stamps for information on any delays. Source: FactSet Markets Diary: Data on U.S. Overview page represent trading ...

Reuters.com is your online source for the latest news stories and current events, ensuring our readers up to date with any ...

Reuters.com is your online source for the latest news stories and current events, ensuring our readers up to date with any ...

Development methodologies combine old and new techniques, but getting any new material into high-volume manufacturing is a ...

The combination of ramucirumab with trifluridine/tipiracil failed to show improvements in overall survival vs TAS-102 alone ...

Charlie CY Yang, an analyst from Bank of America Securities, maintained the Buy rating on Merck & Company (MRK – Research Report).

The stock's fall snapped a five-day winning streak.